Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by brad129on Nov 21, 2022 2:12pm
92 Views
Post# 35116303

RE:RE:Lithloser

RE:RE:Lithloser

that is still over 4 million shares issued, they can do a lot of damage with that especially when we have not much volume, hopefully we get something of substance to drive the price the other way. I just worry they can blow out any momentum as more shares are secured.



LithLover wrote: $25 million is available. Not taken.  Big difference.

The initial offering announced today is only $280,000.  Now why is that?  If $25 million is the amount contracted why only start off with $280,000.  Why not $1 million, $2 million etc.  Why take only 1% of the funds?  Is this why?     

"StageZero's ability to avail itself of the CC will be dependent on its share price and the consequential impact on dilution."

Is it that Tripp expects that only $280,000 is needed at this level but the day to day operations are all but covered and with announcements coming soon there is no need to dilute at this level and the next big push will be at a much higher share price. 

I realize you didn't complete your high school education but $280,000 does not equal $25 million?




 

4real4ever wrote:

 

You said 2 months ago that they just needed the little PP

they made and now you try to justify the 25 millions

 

As pathetic than Nailoser, Gojo, Myrdszzz, brady etc

 

 

Blindness GIFs | Tenor





<< Previous
Bullboard Posts
Next >>